Jefferies Says Las Vegas Sands (LVS) Results Not Good Enough
Get Alerts LVS Hot Sheet
Price: $46.56 +2.42%
Rating Summary:
27 Buy, 12 Hold, 0 Sell
Rating Trend: Up
Today's Overall Ratings:
Up: 5 | Down: 3 | New: 2
Rating Summary:
27 Buy, 12 Hold, 0 Sell
Rating Trend: Up
Today's Overall Ratings:
Up: 5 | Down: 3 | New: 2
Join SI Premium – FREE
Jefferies reiterated their Hold rating and $45 price target on Las Vegas Sands (NYSE: LVS) following results after the close.
The firm states, "While the quarter reflected stronger than expected results in Macau, Singapore and Las Vegas were softer than expected on a hold-adjusted basis. As such, we believe the regulatory overhang should limit the Street's willingness to give LVS the benefit of the doubt and view the results as bearish for the shares. We reiterate our HOLD rating."
The firm raised FY11 EPS estiamtes from $1.71 to $1.81 and FY12 from $2.03 to $2.23.
For more ratings news on Las Vegas Sands click here and for the rating history of Las Vegas Sands click here.
Shares of Las Vegas Sands closed at $45.87 yesterday.
The firm states, "While the quarter reflected stronger than expected results in Macau, Singapore and Las Vegas were softer than expected on a hold-adjusted basis. As such, we believe the regulatory overhang should limit the Street's willingness to give LVS the benefit of the doubt and view the results as bearish for the shares. We reiterate our HOLD rating."
The firm raised FY11 EPS estiamtes from $1.71 to $1.81 and FY12 from $2.03 to $2.23.
For more ratings news on Las Vegas Sands click here and for the rating history of Las Vegas Sands click here.
Shares of Las Vegas Sands closed at $45.87 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Las Vegas Sands (LVS) PT Lowered to $65 at Mizuho
- UBS Reiterates Buy Rating on BioMarin Pharmaceutical Inc. (BMRN)
- Las Vegas Sands (LVS) PT Lowered to $62 at Deutsche Bank
Create E-mail Alert Related Categories
Analyst CommentsRelated Entities
Jefferies & CoSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!